EP Patent

EP1353674A1 — Method for treating glaucoma ivb

Assigned to Synvista Therapeutics Inc · Expires 2003-10-22 · 23y expired

What this patent protects

Provided, among other things, is a method of decreasing intraocular pressure or improving ocular accommodation in an animal, including a human, comprising administering an intraocular pressure decreasing or ocular accommodation improving amount of a compound of the formula (I): H…

USPTO Abstract

Provided, among other things, is a method of decreasing intraocular pressure or improving ocular accommodation in an animal, including a human, comprising administering an intraocular pressure decreasing or ocular accommodation improving amount of a compound of the formula (I): Het-Y.

Drugs covered by this patent

Patent Metadata

Patent number
EP1353674A1
Jurisdiction
EP
Classification
—
Expires
2003-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Synvista Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.